CL2008000380A1 - PHARMACEUTICAL COMPOSITION INCLUDING A MUSCARINIC ANTAGONIST AND A BETA 2-ADRENOCEPTOR ANTAGONIST; PHARMACEUTICAL KIT THAT INCLUDES SUCH PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT A CHRONIC OBSTRUCTIVE PULMONARY DISEASE. - Google Patents
PHARMACEUTICAL COMPOSITION INCLUDING A MUSCARINIC ANTAGONIST AND A BETA 2-ADRENOCEPTOR ANTAGONIST; PHARMACEUTICAL KIT THAT INCLUDES SUCH PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT A CHRONIC OBSTRUCTIVE PULMONARY DISEASE.Info
- Publication number
- CL2008000380A1 CL2008000380A1 CL200800380A CL2008000380A CL2008000380A1 CL 2008000380 A1 CL2008000380 A1 CL 2008000380A1 CL 200800380 A CL200800380 A CL 200800380A CL 2008000380 A CL2008000380 A CL 2008000380A CL 2008000380 A1 CL2008000380 A1 CL 2008000380A1
- Authority
- CL
- Chile
- Prior art keywords
- pharmaceutical composition
- antagonist
- pharmaceutical
- beta
- treat
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 title 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 239000000674 adrenergic antagonist Substances 0.000 title 1
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 title 1
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0702385.6A GB0702385D0 (en) | 2007-02-07 | 2007-02-07 | New combination |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008000380A1 true CL2008000380A1 (en) | 2008-08-18 |
Family
ID=37898913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200800380A CL2008000380A1 (en) | 2007-02-07 | 2008-02-06 | PHARMACEUTICAL COMPOSITION INCLUDING A MUSCARINIC ANTAGONIST AND A BETA 2-ADRENOCEPTOR ANTAGONIST; PHARMACEUTICAL KIT THAT INCLUDES SUCH PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT A CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20110046191A1 (en) |
EP (1) | EP2124941A1 (en) |
JP (1) | JP5337054B2 (en) |
KR (1) | KR20090114389A (en) |
CN (2) | CN101636390B (en) |
AR (1) | AR065202A1 (en) |
AU (1) | AU2008212649B2 (en) |
BR (1) | BRPI0806966A2 (en) |
CA (1) | CA2675718A1 (en) |
CL (1) | CL2008000380A1 (en) |
GB (1) | GB0702385D0 (en) |
MX (1) | MX2009008363A (en) |
PE (1) | PE20081751A1 (en) |
RU (1) | RU2460527C2 (en) |
TW (1) | TW200901986A (en) |
UA (1) | UA99604C2 (en) |
WO (1) | WO2008096126A1 (en) |
ZA (1) | ZA200905106B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0516313D0 (en) * | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
GB0704000D0 (en) * | 2007-03-01 | 2007-04-11 | Astrazeneca Ab | Salts 670 |
BRPI0822693A2 (en) | 2008-05-13 | 2015-07-07 | Astrazeneca Ab | Quinuclidine derivatives as m3 muscarinic receptor antagonists |
CN102131505A (en) * | 2008-06-20 | 2011-07-20 | 阿斯利康(瑞典)有限公司 | Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity |
GB0814728D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
GB0823140D0 (en) * | 2008-12-18 | 2009-01-28 | Astrazeneca Ab | New combination |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
WO2011011060A1 (en) | 2009-07-22 | 2011-01-27 | Puretech Ventures | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
CA3180743A1 (en) | 2018-09-28 | 2020-04-02 | Karuna Therapeutics, Inc. | Composition comprising xanomeline and trospium for treating disorders ameliorated by muscarinic receptor activation |
CN109896934A (en) * | 2019-03-08 | 2019-06-18 | 山东省药学科学院 | A kind of preparation method of high-purity 2- benzyloxy bromoethane |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0307141B1 (en) * | 1987-09-10 | 1993-01-13 | MERCK SHARP & DOHME LTD. | Oxazoles and thiazoles for the treatment of senile dementia |
FR2675142B1 (en) * | 1991-04-10 | 1993-06-25 | Roussel Uclaf | NOVEL DERIVATIVES OF ALPHA-METHYLENE 4 - [(PHENOXY) METHYL] 5-THIAZOLACETIC ACID, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF AND THEIR APPLICATION AS FUNGICIDES. |
GB9603755D0 (en) * | 1996-02-22 | 1996-04-24 | Pfizer Ltd | Therapeutic agents |
US6057340A (en) * | 1998-02-03 | 2000-05-02 | American Home Products Corporation | Oxazole derivatives as serotonin-1A receptor agonists |
US6242448B1 (en) * | 1998-12-17 | 2001-06-05 | American Home Products Corporation | Trisubstituted-oxazole derivatives as serotonin ligands |
SE9902935D0 (en) * | 1999-08-18 | 1999-08-18 | Astra Pharma Prod | Pharmaceutical compositions |
US20020052312A1 (en) * | 2000-05-30 | 2002-05-02 | Reiss Theodore F. | Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists |
US20020189610A1 (en) * | 2001-02-01 | 2002-12-19 | Karl-Heinz Bozung | Pharmaceutical compositions containing an ipratropium salt and a betamimetic |
US20020179087A1 (en) * | 2001-02-01 | 2002-12-05 | Karl-Heinz Bozung | Pharmaceutical compositions containing an oxitropium salt and a betamimetic |
US7417051B2 (en) * | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
EP2319584A1 (en) * | 2002-08-29 | 2011-05-11 | Cipla Ltd. | Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium |
US7332175B2 (en) * | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
US20050025718A1 (en) * | 2003-07-31 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
US7745621B2 (en) * | 2004-05-14 | 2010-06-29 | Boehringer Ingelheim International Gmbh | Long acting bronchodilators for the treatment of respiratory diseases |
GB0516313D0 (en) * | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
TW200738658A (en) * | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
WO2008017827A2 (en) * | 2006-08-08 | 2008-02-14 | Argenta Discovery Limited | Azole and thiazole derivatives and their uses |
WO2008096093A1 (en) * | 2007-02-06 | 2008-08-14 | Argenta Discovery Ltd. | Oxazole and thiazole derivatives and their uses |
-
2007
- 2007-02-07 GB GBGB0702385.6A patent/GB0702385D0/en not_active Ceased
-
2008
- 2008-02-05 TW TW097104738A patent/TW200901986A/en unknown
- 2008-02-06 MX MX2009008363A patent/MX2009008363A/en active IP Right Grant
- 2008-02-06 RU RU2009133261/15A patent/RU2460527C2/en not_active IP Right Cessation
- 2008-02-06 BR BRPI0806966-2A2A patent/BRPI0806966A2/en not_active IP Right Cessation
- 2008-02-06 UA UAA200907421A patent/UA99604C2/en unknown
- 2008-02-06 PE PE2008000265A patent/PE20081751A1/en not_active Application Discontinuation
- 2008-02-06 CA CA002675718A patent/CA2675718A1/en not_active Abandoned
- 2008-02-06 KR KR1020097016484A patent/KR20090114389A/en not_active Application Discontinuation
- 2008-02-06 CN CN2008800045221A patent/CN101636390B/en not_active Expired - Fee Related
- 2008-02-06 AU AU2008212649A patent/AU2008212649B2/en not_active Ceased
- 2008-02-06 AR ARP080100504A patent/AR065202A1/en unknown
- 2008-02-06 EP EP08702062A patent/EP2124941A1/en not_active Withdrawn
- 2008-02-06 JP JP2009548735A patent/JP5337054B2/en not_active Expired - Fee Related
- 2008-02-06 US US12/523,171 patent/US20110046191A1/en not_active Abandoned
- 2008-02-06 CN CN2008800106615A patent/CN101678005B/en not_active Expired - Fee Related
- 2008-02-06 WO PCT/GB2008/000404 patent/WO2008096126A1/en active Application Filing
- 2008-02-06 CL CL200800380A patent/CL2008000380A1/en unknown
-
2009
- 2009-07-21 ZA ZA200905106A patent/ZA200905106B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101636390A (en) | 2010-01-27 |
WO2008096126A1 (en) | 2008-08-14 |
PE20081751A1 (en) | 2008-12-27 |
BRPI0806966A2 (en) | 2014-04-08 |
ZA200905106B (en) | 2010-05-26 |
TW200901986A (en) | 2009-01-16 |
CN101678005B (en) | 2012-10-31 |
JP5337054B2 (en) | 2013-11-06 |
KR20090114389A (en) | 2009-11-03 |
GB0702385D0 (en) | 2007-03-21 |
JP2010518059A (en) | 2010-05-27 |
CN101678005A (en) | 2010-03-24 |
AU2008212649B2 (en) | 2011-05-19 |
AR065202A1 (en) | 2009-05-20 |
RU2460527C2 (en) | 2012-09-10 |
RU2009133261A (en) | 2011-03-20 |
MX2009008363A (en) | 2009-08-20 |
CN101636390B (en) | 2013-06-12 |
US20110046191A1 (en) | 2011-02-24 |
UA99604C2 (en) | 2012-09-10 |
AU2008212649A1 (en) | 2008-08-14 |
CA2675718A1 (en) | 2008-07-14 |
EP2124941A1 (en) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008000380A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A MUSCARINIC ANTAGONIST AND A BETA 2-ADRENOCEPTOR ANTAGONIST; PHARMACEUTICAL KIT THAT INCLUDES SUCH PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT A CHRONIC OBSTRUCTIVE PULMONARY DISEASE. | |
BRPI0818193A2 (en) | compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, and use of a compound | |
CL2007002967A1 (en) | CRYSTAL FORM A OF THE COMPOUND 4- [3- (4-CYCLOPROPANCARBONIL-PIPERAZIN-1-CARBONIL) -4-FLUORO-BENCIL] -2H-FTALAZIN-1-ONA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF A | |
DK1984009T3 (en) | Pharmaceutical compositions with improved stability | |
BRPI0720124A2 (en) | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE. | |
CL2008000510A1 (en) | FARMACO-LIGANDOS CONJUGATED COMPOUNDS, THAT JOIN POWERFUL CITOTOXINS; PHARMACEUTICAL COMPOSITION; AND USE TO DELAY OR STOP THE GROWTH OF A TUMOR IN A MAMMER. | |
CL2007001992A1 (en) | COMPOUNDS DERIVED FROM PYRIMIDILCICLOPENTANOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AN INFLAMMATORY, HYPERPROLIFERANT, CARDIOVASCULAR, NEURODEGE DISEASE | |
BRPI0917540A2 (en) | compound, pharmaceutically acceptable salt, pharmaceutical composition, and use of a pharmacologically acceptable compound or salt | |
CL2007002752A1 (en) | COMPOUNDS DERIVED FROM 3- (4-OXO-4H-QUINAZOLIN-3-IL) -PIPERIDINA-2,6-DIONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT OR PREVENT DISEASES SUCH AS CANCER, PAIN, MACULAR DEGENERATION, PULMONARY DISORDER, TR | |
BRPI0813456A2 (en) | COMPOSITION, USE OF THE SAME, PHARMACEUTICAL COMPOSITION, AND METHODS TO TREAT A MAMMAL WITH A DISORDER AND DISEASE | |
BRPI0810696A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND | |
CL2013000801A1 (en) | Pharmaceutical composition comprising a rankl inhibitor and a hormone or a derivative thereof, and use of the rankl inhibitor to prepare said composition | |
BRPI0817200A2 (en) | solid ophthalmic compositions and use of pharmaceutical manufacturing compounds | |
BRPI0813955A2 (en) | therapeutic compositions and their use | |
BRPI0811865A2 (en) | HYPEROCYCLIC HYPEROCYCLIC DERIVATIVES, THE PREPARATION AND PHARMACEUTICAL USE OF THE SAME | |
BRPI0810161A2 (en) | COMPOUND, PHARMACEUTICAL PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE OF A COMPOUND | |
CL2008000408A1 (en) | INHIBITING PIRROLIDIN-AMIDA DERIVATIVE COMPOUNDS OF THE PROTEASA ACTIVADORA DE CANAL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT CHYSICAL FIBROSIS, CHRONIC BRONCHITIS, LUNG CANCER BETWEEN OTHER DISEASES | |
CL2007003260A1 (en) | COMPOUNDS DERIVED FROM AZABICICLO [2.2.2] OCTANO; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE. | |
BRPI0816389A2 (en) | COMPOSITIONS OF FILTABLE FUNGAL TOTAL CELLULASE EMPLOYED BY BETA GLYCOSITY AND METHODS OF USE | |
BRPI0814769A2 (en) | SYNERGIC COMPOSITION UNDERSTANDING FLAVORING SUBSTANCES AND ORGANIC ACIDS AND USE OF THE SAME | |
ATE493119T1 (en) | PHARMACEUTICAL COMPOSITION | |
BRPI0815821A2 (en) | COMPOSITIONS AND METHODS USING NMDA ANTAGONISTS TO ACHIEVE ANESTHETICS SAVING EFFECT. | |
IT1403847B1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA AND THEIR USE. | |
CL2008000060A1 (en) | COMPOUNDS DERIVED FROM 1-CARBOXI-2-AMIDA PIRROLIDINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT CHYSICAL FIBROSIS, PULMONARY CARCINOMA, CHRONIC BRONCHITIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA OR AN INF | |
CL2007002494A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES A PIRIMIDINE TRISUSTITUIDA IN COMBINATION WITH A COMPOUND WITH INHIBITORY PROPERTIES OF PDE5; AND USE IN THE TREATMENT OF A DISEASE THAT INVOLVES VASOCONSTRICTION. |